INTRODUCTION
Neurohumors may be defined as highly active, naturally-occurring substances involved in neuronal activity, that are found in the nervous system in such minute concentrations, as to generally require bioassay techniques for their determination. (Spectrophotofluorimetric methods have also been used for this purpose in recent years). Substances usually considered as neurohumors are listed as follows:
1. Acetylcholine a quarternary ammonium compound 2. Biogenic aminesa. catecholamines (i) noradrenaline (ii) adrenaline b. 5-Hydroxytryptamine (serotonin) c. Histamine Substance P (a polypeptide) and dopamine (a catecholamine) have also been considered as potential neurohumors, but have never been reported in cerebrospinal fluid. The same is true of gamma-aminobutyric acid (GABA), although the peculiarly high concentrations of this substance found in brain would make GABA an exception to the rule that neurohumors are found in minute amounts in nervous tissue.
Giarmane and Crossland17 have recently published reviews of current concepts of the neurophysiological significance of these substances found in brain. Briefly, it may be stated that neurohumors are thought to play a role in transmission of the nerve impulse, both in the peripheral and central nervous systems. This role may be that of direct synaptic transmission of the impulse to the subsynaptic membrane, as is probable with acetylcholine, or it may be that of a 'neuroregulatory' agent modulating neural function in some, as yet unknown, manner. This latter concept has been developed as a result of the accumulation of a large body of data on amines that refuses to fall into any simple scheme and yet makes it apparent that many of these substances are intimately involved in neuronal activity.
The problem of interpretation of data resulting from analysis of brain homogenates, as applied to the physiology of the living brain, has always been the subject of much concern to workers in this field. Acetylcholine, the neurohumor most intensively studied, is a highly labile substance prone to rapid enzymatic and nonenzymatic destruction when in the free form. Furthermore, study of these substances in human beings usually precludes direct analysis of the brain. For these reasons, attention has been directed to CSF as a potential source of information in living animals. The fundamental assumption upon which such studies are based is that neurohumors liberated into the synaptic cleft may diffuse out into the surrounding area, and under certain circumstances, may be detected in CSF. It is apparent that it is a long road from synaptic cleft to CSF and many problems arise in interpreting such data. The most obvious of these is the lack of knowledge as to the specific site of origin of the neurohumor detected. Other questions to be raised pertain to the rates of appearance and disappearance of these substances in CSF. Monamine oxidase activity' and acetylcholinesterase are both present in CSF, presumably capable of acting on appropriate substrates.* Nonenzymatic destruction may also occur.
The site of withdrawal of CSF is also an important factor to consider in interpreting results. Many of the substances to be reviewed here have been found in ventricular and cisternal fluid but not in lumbar CSF. Histamine shows an opposite distribution as it is found in higher concentrations in lumbar fluid.: The reason for these variations is not entirely clear but is *It appears that levels of acetylcholine which are usually found in CSF are too small to allow it to act as an effective substrate for acetylcholinesterase." The same may be true of 5-hydroxytryptamine, since relatively large amounts of 5-HT are required to demonstrate monamine oxidase activity.' Thus the minute concentrations of neurohumors in CSF may protect them from enzymatic destruction.
# Actually most substances in CSF (glucose is an exception) are present in higher concentrations in a cranio-caudal direction. ' Prior to the extensive development of neurohumoral physiology, substances with oxytocic, pressor, antidiuretic and chromatophore-stimulating properties had been described in CSF. Many of the first workers thought these effects were due to posterior pituitary substance secreted into the CSF via the third ventricle. For this historical reason, the studies on 'posterior pituitarylike' substances have been considered first in this review.
Cushing and Goetsch" were the first modern workers to investigate the biological properties of CSF. They reported in 1910 that CSF obtained from human hydrocephalics caused a definite biphasic change in the blood pressure of a rat, initiated peristalis in the rat, and caused dilatation of the isolated frog's pupil. They speculated that these changes were due to pituitrin in the CSF occurring by virtue of the proximity of the third ventricle to the posterior lobe of the pituitary gland. This observation was not further pursued until the 1920's when other investigators began publishing reports along similar lines. Dixon2' stated that the fluid obtained from the subcerebellar cistern of dogs "show every known chemical and physiological effect of pituitrin." Miura" and Trendelenburg9 demonstrated oxytocic and melanophore-stimulating effects of CSF obtained from rabbits. Mestrezat and van Caulaert' stated that the oxytocic action was present in CSF obtained via cisternal puncture of dogs and humans with 'mental disease' but not when obtained by lumbar puncture. Hoff and Wermer& claimed that the oxytocic factor obtained from cisternal fluid of dogs, was much increased by exposing the dogs to cats prior to withdrawal of fluid. Karplus and Peczenik,40 in a series of carefully described experiments, reported that electrical stimulation of the hypothalamus or tuber cinereum of the cat caused an oxytocic substance to be released into CSF. Stimulation of the cervical sympathetic nerves or nervus ischiadicus did not elicit this effect. In addition to the oxytocic effect, a substance was also elicited that would darken the erythrophores of the minnow. They concluded that pituitrin and intermedin were liberated into the CSF under the influence of hypothalamic activity. This work may be considered as a forerunner of the present day intense interest in hypothalamic-pituitary relationships.
Van Dyke et al. 7 ' criticized the methodology of some of the above-mentioned papers and stated, on the basis of their own experiments, that the oxytocic effect of CSF was really due to its increased calcium concentration as compared to the usual perfusion fluids for guinea pig uterus. However, Cushing concluded that the question of the presence of ADH in CSF is still unsettled. In attempting to critically assess this array of contradictory reports that are usually not comparable, one is left with the feeling that pharmacologically active substances can be induced to appear in CSF by virtue of various stimulatory techniques. CSF obtained from ventricular or cisternal areas have higher concentrations of these substances than that obtained from lumbar sites. It seems impossible that all these effects could be due to artifacts in the experiments (e.g. high calcium content of perfusion fluid). However, it is entirely unclear as to whether these substances are related in any way to the polypeptide hormones of the neurohypophysis. The activity of the neurohumors to be discussed subsequently may have substantially contributed to these findings as they were only beginning to be appreciated at the time most of this work was done. Acetylcholine antagonists, such as atropine, were usually not added to perfusion fluids although Unga' briefly mentions that his effects were not abolished by atropine. He also states that his contractions were more persistent than those induced by either histamine or acetylcholine, but supplies no details upon which to evaluate his statements.' Some pharmacological properties of the cerebral neurohumors are listed in Table 2 to illustrate how their presence could easily simulate posterior pituitary substances in CSF. Only the chromatophore-darkening effects cannot be explained in this way since neurohumors actually tend to oppose melanin stimulating hormone (lightening effect.)" However, adrenocorticotrophic hormone, which has also been reported in CSF (see below), has darkening activity similar to MSH. In general, one might suspect that many of the effects described above were due to neurohumoral substances in the CSF, but only further studies, utilizing our present knowledge of the properties of neurohumors, can satisfactorily resolve this problem. There are a few reports on the presence of anterior pituitary hormones in CSF. Van Bogaert and van Baarle76 described a corticotrophic effect of CSF obtained from hypertensive dogs and humans. Lachnit and Weis' claimed that ACTH activity, as determined by ascorbic acid depletion in rats' adrenals, can be demonstrated in the CSF of patients with 'pituitary basophilism', while patients with primary adrenal disease did not show this phenomenon. They utilized this technique as an aid in differential diagnosis of these two conditions. Similarly, Soucek' reported that 3 out of 4 cases with Cushing's disease due to pituitary tumors had CSF that gave positive Aschheim-Zondek reactions. This was interpreted as indicating the presence of gonadotrophic hormone in CSF. pheral nerves. They also mention that while stimulation of the motor and cerebellar cortex is without effect, stimulation of the hypothalamus produced doubling of the Ach levels in 7 out of 14 animals studied. It is of some interest, in view of the reports summarized in the first section of this paper, that the authors state that perfusion of the ventricular system with pituitrin (10 units/cc) caused doubling of the Ach concentration, while perfusion with adrenaline had no effect.
Bornsteine0 in 1946 published a widely-quoted report on the presence and effect of Ach in CSF of cats subjected to experimental head trauma. He showed that Ach consistently appeared in CSF obtained by cisternal puncture of these animals in concentrations of 0.027-0.090 ,gm/cc. The Ach could be demonstrated up to 48 hours after the trauma and then disappeared. The animals themselves initially showed tonic-clonic seizures, apnea, loss of placing reactions and finally stupor. Electroencephalograms revealed paroxysmal high-amplitude bursts of activity at first and then diminished activity with stupor. Bornstein stated that the EEG patterns and stuporous condition could be reversed by administration of atropine in doses of 0.5-1.0 mgm/kg although loss of placing reactions remained.
He also claimed that administration of intracisternal Ach duplicated both the behavioral and EEG picture of traumatized animals and could be suppressed with atropine. On the basis of this study, Ward'8 and later Jenkner88, 9 gave anticholinergic drugs to patients with closed craniocerebral trauma and reported striking results in some instances, particularly with Jenkner's use of the centrally-acting phenothiazine 'diparcol.' Frequent surveys have been conducted on patients with neurologic and psychiatric disorders for the purpose of searching for Ach in the CSF. Bioassay preparations used include the dorsal muscle of the leech,24'""' the frog lung"12' the frog abdominal rectus muscle,"'" and most recently, the heart of the mollusc Mercenaria (Venus) mercenaria."' 5 7W.'W,67 ' tics." At the same time, he describes a 'curare-like' substance present only in the CSF of schizophrenics and paretics, which had the effect of relaxing the leech muscle utilized for the assay. This substance antagonized Achinduced contractions of the muscle but did not affect potassium-induced contractions. It was highly stable as opposed to Ach which required Tower's method of preservation in CSF (neostigmine plus acidification of CSF Kunkle' has reported Ach in CSF of 5 out of 9 patients with migraine headaches while no Ach was found in 35 of 37 patients without migraine. The two patients of this latter group who were free of migraine but did have Ach in their CSF were subject to grand mal seizures.
Bhattacharya, Feldberg, and Vogt7 have further complicated matters by reporting a substance in human CSF that sensitizes frog rectus muscle to Ach which is demonstrated when the Ach is added subsequently. They feel that this agent may be a lipoprotein normally present in CSF. A similar phenomenon utilizing the clam heart as a test object has been noted. '9 In reviewing these diverse reports of Ach in CSF, the same problems of comparability arise as with posterior pituitary-like substances. A few generalizations, however, can be formulated. Experimental electrical or chemical stimulation of the CNS in an appropriate manner, as reviewed above, will cause Ach to appear in the CSF of eserinized animals. Concentrations of Ach can be frequently found in CSF in many disease states, and may even be normally present in human CSF. The problem of deciding upon a normal range, and making valid clinical correlations with elevations above this, is almost impossible at this time. A rough approximation might indicate 0.001 jugm/cc as a dividing line under which investigators have frequently found Ach in CSF. Levels of 0.01 to 1.0 ,ugm/cc have usually been only found in certain neurological disorders, which at this time include seizure disorders, craniocerebral trauma, and possibly migraine headaches.
Poloni's report of a curare-like substance associated with the absence of Ach in the CSF of 48 out of 50 schizophrenics seems particularly surprising in view of the current trend of thought that schizophrenia is a disease of multiple etiology. Although none of the other studies reviewed here indicated such an association, Poloni's claim has never been specifically disproved in the literature.
HISTAMINE
The first reported study of histamine in CSF was by Zadina and Petran' in 1938. They mention finding "very small amounts of histamine" in CSF of most patients studied and increased amounts in two cases of schizophrenia. Trabucchi'6 measured histamine in the CSF of 20 normal and schizophrenic patients. He stated that histamine was never present in concentrations over 0.01 ugm/cc in any of the cases and could not relate the height of the levels to the diagnosis.
In 1949, three different papers appeared almost simultaneously reporting data on determinations of histamine in CSF and reviewing the literature up to that time. Autio and Ermala,3 using the guinea pig duodenum as their test object, found average levels of 0.043 ygm/cc in CSF of neuropsychiatric patients obtained by cisternal puncture, and 0.091 when obtained by lumbar puncture. This is an interesting finding in view of subsequent reports of unusually high histamine concentrations in dorsal root ganglia. They found that extraction of histamine with a conventional trichloracetic acid technique yielded higher values than when CSF was directly added to the test organ. Jackson and Rose,37 using a similar method, report much lower levels in CSF, averaging 0.01 ,ugm/cc with a range of 0.002 to 0.03 ugm/cc. The highest level was found in a case of trigeminal neuralgia. No associations were made, other than that patients with high CSF cell counts tended to have higher histamine levels. Corrado Sachs' first reported this substance to be present in CSF of patients following craniocerebral trauma. He utilized as his test object, the clam heart (Venus mercenaria), a preparation that is particularly useful in surveys of CSF because it is highly sensitive to both 5-HT and Ach. 5-HT produces increased contractility of the heart while Ach produces the opposite effect. Positive identification of these substances is usually felt to be reasonably acceptable with the use of specific antagonists such as lysergic acid diethylamide (LSD) for 5-HT and benzoquinonium ('Mytolon') for Ach. Sachs found 5-HT as well as Ach in a number of the patients he investigated, thus enlarging upon Tower's earlier reports that Ach appears in the CSF of patients undergoing head trauma.
Bogdanski, Weissbach, and Udenfriend,8 as part of their pharmacological analysis of 5-hydroxytryptophan, reported that 5-HT appears in the CSF of cats and dogs up to levels of 0.14 ugm/cc following administration of 5-HTP (a precursor of 5-HT). The authors have shown that brain 5-HT increases up to tenfold, and is associated with marked behavioral and autonomic changes which they interpret as resembling an LSD effect. The significance of these findings awaits an understanding of the role played by 5-HT in the brain. Feldtman, Izak, and Nelkeni could not find significant amounts of 5-HT in CSF of patients with multiple sclerosis and other neurological disorders. Turner and Mauss' have reported an extensive series of cases, as mentioned in the Ach section, utilizing the clam heart in the same way as Sachs did. They studied raw spinal and ventricular fluids from subjects with schizophrenia and a variety of neurological conditions (see Table 5 ). 5-HT was found in about one-third of all fluids studied. No significant correlations could be made between the levels found and the diagnostic groups studied. It appears that there is a tendency for ventricular fluids to have higher 5-HT levels, although the authors did not feel that this was a significant difference.
Freedman, Giarman, and Picard-Ami,' testing a 95%o acetone extract of CSF on the clam heart, have been able to detect on only rare occasions minute amounts of 5-HT (under 0.01 pgm/cc) in the CSF of schizophrenic patients. Schain studied a group of 30 specimens of raw lumbar CSF from subjects with various neuropsychiatric disorders, using the clam heart and the rat uterus in estrus. 5-HT could be definitely identified on only one occasion (infantile autism). It has been noted that most CSF stabilizes and increases the height of the base-line contraction of the heart. Subsequent to this effect, many hearts become more sensitive to additions of the standard solution of 5-HT. These phenomena may often hinder the assayist from accurately assessing the presence and level of 5-HT in CSF.
The levels of 5-HT in CSF reported by Turner and Mauss tend to approach the lower limits of sensitivity of the clam heart to 5-HT by the usual assay methods. Some doubt must be expressed as to whether levels under .005-.01 ,ugm/cc can be accurately identified as 5-HT. Furthermore, data obtained by techniques utilizing relatively purified extracts of 5-HT, may be looked upon with considerably more confidence than those derived from raw body fluids. This problem of the use of raw fluids in bioassay procedures will be discussed again below.
POLYPEPTIDES
Chapman and Wolff`have reported the presence of a proteolytic enzyme in the CSF of patients with active inflammatory or degenerative central nervous system disease, migraine headaches, prolonged pain, and chronic schizophrenia. This protease is identified by virtue of its capacity to form what appears to be a biologically-active polypeptide (bradykinin) when CSF is incubated with a globulin-containing solution. The polypeptide is assayed on rat uterus or guinea pig ileum. Sometimes the CSF seems to contain the polypeptide even without incubation with globulin which the authors attribute to the action of the protease on CSF globulins in 7nvo.
Many biologically active polypeptides have been detected in body fluids and tissues, and have been the subject of much investigation.' One of them, Substance P, is found in appreciable amounts in the brain and has been considered as a possible neurohumoral transmitter. Posterior pituitary substance mentioned previously as frequently reported in CSF, is now known to be a mixture of several polypeptides with different pharmacological effects that are found in the neurosecretory elements of the hypothalamus and the hypothalamic-hypophysed tract. The possible relationship of local neurosecretion to brain function is of much interest but beyond the scope of this review.
DISCUSSION
The chaotic mass of data reviewed above does not lend itself readily to critical analysis. Furthermore, the fact that there is no real understanding of the normal role played by neurohumors in the CNS complicates the problem still more. Nevertheless, the author feels that investigating the patterns of neurohumors in CSF offers a parameter for study that may directly reflect the dynamics of brain function, and should be pursued in spite of the lack of clarity of the field.
The data reviewed on 'posterior pituitary-like' substances in CSF clearly indicate that an agent (or agents) with diverse pharmacological effects appears in increasing concentration in CSF when certain CNS stimuli are applied. Reinvestigation of this problem should be attempted in light of our extensive knowledge of the properties of neurohumors as well as polypeptide hormones.
The presence of measurable Ach in CSF has been clearly established in many experimental and clinical situations, although the levels found vary greatly. The association of increased Ach levels with craniocerebral trauma and epilepsy seems definite. It has been felt that this represents a massive release of Ach from neurons secondary to trauma or seizure activity. This is certainly true of trauma, but one might speculate whether epileptics are frequently releasing excessive amounts of Ach that is a sign of their predisposition to seizures. The fact that elevated Ach levels have been found in the CSF of epileptics during interictal periods' would support such a hypothesis. There is some evidence that convulsions produced by electroshock therapy do not produce Ach elevations as readily as naturally occurring seizures do."' The data on choline acetylase activity in epileptogenic cortex has been contradictory,' but the increasing emphasis at present on techniques of studying particulate (bound) Catecholamines in CSF undoubtedly reflect plasma levels of these substances. 5-HT in blood is almost entirely bound to platelets, and it is not surprising that 5-HT is not as readily detectable in CSF as are catecholamines. Where 5-HT is found, it would be worthwhile to study the sediment of centrifuged CSF to see if the cellular elements are the source of 5-HT, as seems to be often true of histamine.'
A few other suggestions regarding further investigations of this type may be made. Although the surveys of heterogeneous patient groups described above are initially necessary, continued advances will now probably come as the result of sustained studies of specific pathological states where promising leads have been found. One such area is the association of Ach in CSF with convulsive disorders. The study of psychomotor seizure states might be a particularly fruitful type of fit to study in view of the high levels of neurohumors found in certain regions of the 'limbic system."' If 5-HT from neural sources were ever to make its appearance in CSF, one might think this should occur during a psychomotor seizure originating from an area rich in 5-HT. It would be of interest to correlate CSF findings with EEG studies in the so-called 'epileptic equivalent' states, e. g. abdominal pain, headaches, nightmares, etc., that are thought to be at times the manifestations of seizure disorders. Identification of these symptoms as epileptic equivalents is often quite difficult, and evidence of abnormal Ach or other neurohumoral levels in CSF would be of much interest.
Poloni's provocative report has not been mentioned again in the literature, except by Turner and Mauss, as far as the writer has been able to determine. His findings should be either confirmed or disproved, for if true, they would have major implications regarding a neurohumoral abnormality in schizophrenia.*
The study of neurohumors in CSF in association with the administration of drugs is a second approach that might provide pertinent information regarding the mechanism of action of neurotropic drugs. Evidence is accumulating that these preparations exert their effect by acting on neurohumoral mechanisms. It would seem reasonable that administration of such drugs might be associated with the appearance of neurohumors in the CSF or with changes of levels already present. taneous development of marked behavioral changes. A well-known older observation is the fact that administration of an anticholinesterase such as eserine, causes Ach to appear in the CSF.78 " Possibly other enzymatic inhibitors such as monamine oxidase inhibitors, would cause other neurohumors to appear in CSF in an analogous fashion. Drugs such as reserpine that are thought to decrease the binding capacity of subcellular particles for amines, might produce similar effects. Speculations of this sort could be easily tested by the analysis of CSF in drug-treated animals.* Cisternal CSF should be obtained more often, rather than relying exclusively on lumbar CSF, since the former may yield positive data where lumbar fluids are negative. Unfortunately, cisternal puncture is rarely attempted in this country or is generally regarded as a dangerous procedure. Actually, this technique is widely used in continental Europe and Schonenberg states that suboccipital (cisternal) puncture is the procedure of choice for obtaining CSF in all but young children or infants.' He reviews the literature and concludes that, while unfortunate sequelae have been reported, they are extremely rare.
A final point that should be emphasized is the necessity for rigorous technique in the use of bioassay procedures. Much of the difficulty with these techniques is due to inadequate separation (or no separation at all) of contaminating tissue factors from the substance to be measured. It is well-known that tissue extracts commonly exert sensitizing effects on biological preparations,"'" and it has been observed above that an unknown substance in CSF will sensitize the response of test organs to Ach and 5-HT. The use of specific pharmacological antagonists for identification is only a partial answer as the antagonists themselves may exert prolonged effects on the test object and will slow down an already time-consuming procedure. Increased emphasis on extraction methods would do much to improve the reproducibility of bioassay results.
Regarding the test object itself, the same biological preparation will vary considerably over a period of time in its sensitivity to active substances. The usual bioassay method requires the bracketing of the unknown between two standards that demonstrate clearcut dose differentiation.* Preliminary 'testing of the sensitivity' without continual use of the standard solution is * a quite unreliable procedure, particularly when using a raw body fluid such as CSF. The significance of the data obtained from bioassay techniques, as in any other laboratory procedures, is directly related to the care taken in attempting to obtain quantitative analysis. SUMMARY 1. The literature dealing with pharmacologically active substances in CSF has been reviewed. Many earlier reports described oxytocic, pressor, antidiuretic and chromatophore-stimulating agents in CSF. These cannot be considered as all artifacts, but the identity of the active principles has not been determined.
2. Acetylcholine is the only pharmacologically active substance of clearly neural origin, that has been specifically identified in CSF. Craniocerebral trauma and seizure states are associated with higher levels of acetylcholine in CSF.
3. Histamine, catecholamines and 5-hydroxytryptamine have all been reported in CSF, but it cannot be assumed that these substances in CSF originate from neural tissue.
4. Certain suggestions for further research have been discussed. These primarily deal with the study of CSF neurohumors in seizure disorders, and following the administration of neurotropic drugs. 5 . Bioassay methodology has been discussed. Much stress has been placed on the importance of using extraction methods prior to assay. The principles and some pitfalls of bioassay technique have been briefly mentioned.
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